Related Experiment Videos
Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction.
1Department of Urology, University of Vienna, Austria.
British Journal of Clinical Pharmacology
|November 1, 1989
Summary
Prostaglandin E1 (PGE1) effectively induces erections in men with erectile dysfunction, showing a clear dose-response relationship. Even low doses of PGE1 are effective, though pain is a potential side effect.
Area of Science:
- Urology
- Pharmacology
- Andrology
Background:
- Erectile dysfunction (ED) is a common condition affecting men's health.
- Intracavernous injection of prostaglandin E1 (PGE1) has shown promise for inducing penile erections.
Purpose of the Study:
- To examine the dose-response relationship of prostaglandin E1 (PGE1) in inducing artificial penile erection.
- To evaluate the efficacy and side effects of different PGE1 doses for erectile dysfunction.
Main Methods:
- A double-blind, cross-over, placebo-controlled study was conducted.
- Twenty patients with psychogenic erectile dysfunction received intracavernous injections of saline with no substance, preservative, 5 µg PGE1, or 10 µg PGE1.
- Erection grade, duration, and latency were assessed.
Main Results:
- Prostaglandin E1 demonstrated a significant dose-dependent effect on erection grade, duration, and latency (P < 0.001).
- Saline and preservative alone did not induce erections.
- Local pain occurred in 11/20 patients at 5 µg and 14/20 patients at 10 µg PGE1, also showing a dose-relation (P = 0.0035).
Conclusions:
- Prostaglandin E1 is a promising agent for diagnosing and treating erectile dysfunction.
- PGE1 is effective at low doses, with 10 µg suggested as an initial diagnostic dose for evaluating the cavernous-vascular system.
- While local pain is a side effect, PGE1's efficacy makes it a valuable therapeutic option.